Migdal Insurance & Financial Holdings’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-227
Closed -$1K 652
2022
Q1
$1K Buy
227
+81
+55% +$727 ﹤0.01% 598
2021
Q4
$2K Sell
146
-5
-3% -$91 ﹤0.01% 670
2021
Q3
$4K Hold
151
﹤0.01% 644
2021
Q2
$8K Sell
151
-51
-25% -$2.28K ﹤0.01% 549
2021
Q1
$9K Sell
202
-63
-24% -$3.01K ﹤0.01% 639
2020
Q4
$11K Sell
265
-8,860
-97% -$336K ﹤0.01% 619
2020
Q3
$372K Buy
9,125
+2,459
+37% +$122K 0.01% 386
2020
Q2
$365K Buy
6,666
+3,662
+122% +$209K 0.01% 315
2020
Q1
$157K Buy
3,004
+442
+17% +$23.9K ﹤0.01% 327
2019
Q4
$125K Buy
2,562
+12
+0.5% +$562 ﹤0.01% 475
2019
Q3
$140K Buy
2,550
+917
+56% +$52.5K ﹤0.01% 513
2019
Q2
$82K Buy
+1,633
New +$81.3K ﹤0.01% 582

Other funds holding TRHC

Migdal Insurance & Financial Holdings's TRHC Position: Q2 2022 in Review

Migdal Insurance & Financial Holdings sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 227 shares — an estimated $1K sold.

Migdal Insurance & Financial Holdings first reported a position in TRHC in Q2 2019 and held it in 12 quarters. The position peaked at $372K in Q3 2020. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 227 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $1K.
  • Migdal Insurance & Financial Holdings first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Migdal Insurance & Financial Holdings's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $372K in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.